Safety, effectiveness, and cost among Texas Medicaid patients with Diabetic Macular Edema (DME) or Age-Related Macular Degeneration (AMD)
Although bevacizumab is one of the most commonly used treatments for DME and AMD, there are concerns regarding safety and effectiveness due to its off-label use. The study objectives were to determine if: 1) the risk of cardiovascular/ hemorrhagic events (safety) and visual impairment (effectiveness...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/28478 |